These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11723798)

  • 1. Analysis of the heterogeneity of pO2 dynamics during photodynamic therapy with verteporfin.
    Pogue BW; Braun RD; Lanzen JL; Erickson C; Dewhirst MW
    Photochem Photobiol; 2001 Nov; 74(5):700-6. PubMed ID: 11723798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of tumor host microenvironment on photodynamic therapy in a rat prostate tumor model.
    Chen B; Pogue BW; Zhou X; O'Hara JA; Solban N; Demidenko E; Hoopes PJ; Hasan T
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):720-7. PubMed ID: 15701861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photodynamic therapy with verteporfin in the radiation-induced fibrosarcoma-1 tumor causes enhanced radiation sensitivity.
    Pogue BW; O'Hara JA; Demidenko E; Wilmot CM; Goodwin IA; Chen B; Swartz HM; Hasan T
    Cancer Res; 2003 Mar; 63(5):1025-33. PubMed ID: 12615718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2.
    Renno RZ; Terada Y; Haddadin MJ; Michaud NA; Gragoudas ES; Miller JW
    Arch Ophthalmol; 2004 Jul; 122(7):1002-11. PubMed ID: 15249365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic induced uptake of liposomal doxorubicin to rat lung tumors parallels tumor vascular density.
    Wang Y; Gonzalez M; Cheng C; Haouala A; Krueger T; Peters S; Decosterd LA; van den Bergh H; Perentes JY; Ris HB; Letovanec I; Debefve E
    Lasers Surg Med; 2012 Apr; 44(4):318-24. PubMed ID: 22362489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study.
    Schmidt-Erfurth U; Miller JW; Sickenberg M; Laqua H; Barbazetto I; Gragoudas ES; Zografos L; Piguet B; Pournaras CJ; Donati G; Lane AM; Birngruber R; van den Berg H; Strong HA; Manjuris U; Gray T; Fsadni M; Bressler NM
    Arch Ophthalmol; 1999 Sep; 117(9):1177-87. PubMed ID: 10496389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the new photosensitizer Stakel (WST-11) for photodynamic choroidal vessel occlusion in rabbit and rat eyes.
    Berdugo M; Bejjani RA; Valamanesh F; Savoldelli M; Jeanny JC; Blanc D; Ficheux H; Scherz A; Salomon Y; BenEzra D; Behar-Cohen F
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1633-44. PubMed ID: 18385085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic therapy with verteporfin in a rabbit model of corneal neovascularization.
    Holzer MP; Solomon KD; Vroman DT; Sandoval HP; Margaron P; Kasper TJ; Crosson CE
    Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):2954-8. PubMed ID: 12824237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining vascular and cellular targeting regimens enhances the efficacy of photodynamic therapy.
    Chen B; Pogue BW; Hoopes PJ; Hasan T
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1216-26. PubMed ID: 15752904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Verteporfin photodynamic therapy in the rat model of choroidal neovascularization: angiographic and histologic characterization.
    Zacks DN; Ezra E; Terada Y; Michaud N; Connolly E; Gragoudas ES; Miller JW
    Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2384-91. PubMed ID: 12091441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical comparison of mTHPC and verteporfin for intracavitary photodynamic therapy of malignant pleural mesothelioma.
    Opitz I; Krueger T; Pan Y; Altermatt HJ; Wagnières G; Ris HB
    Eur Surg Res; 2006; 38(3):333-9. PubMed ID: 16785733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of photodynamic therapy on tumor oxygenation.
    Reed MW; Mullins AP; Anderson GL; Miller FN; Wieman TJ
    Surgery; 1989 Jul; 106(1):94-9. PubMed ID: 2525821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photodynamic Therapy Leads to Time-Dependent Regression of Pathologic Corneal (Lymph) Angiogenesis and Promotes High-Risk Corneal Allograft Survival.
    Hou Y; Le VNH; Clahsen T; Schneider AC; Bock F; Cursiefen C
    Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5862-5869. PubMed ID: 29145577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photodynamic therapy in retinoblastoma: effects of verteporfin on retinoblastoma cell lines.
    Stephan H; Boeloeni R; Eggert A; Bornfeld N; Schueler A
    Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):3158-63. PubMed ID: 18579764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
    Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study.
    Miller JW; Schmidt-Erfurth U; Sickenberg M; Pournaras CJ; Laqua H; Barbazetto I; Zografos L; Piguet B; Donati G; Lane AM; Birngruber R; van den Berg H; Strong A; Manjuris U; Gray T; Fsadni M; Bressler NM; Gragoudas ES
    Arch Ophthalmol; 1999 Sep; 117(9):1161-73. PubMed ID: 10496388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence of early vascular events after photodynamic therapy.
    Michels S; Schmidt-Erfurth U
    Invest Ophthalmol Vis Sci; 2003 May; 44(5):2147-54. PubMed ID: 12714655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating the effect of ciliary body photodynamic therapy in a glaucoma mouse model.
    Matsubara A; Nakazawa T; Husain D; Iliaki E; Connolly E; Michaud NA; Gragoudas ES; Miller JW
    Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2498-507. PubMed ID: 16723462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodynamic therapy of multiple nonmelanoma skin cancers with verteporfin and red light-emitting diodes: two-year results evaluating tumor response and cosmetic outcomes.
    Lui H; Hobbs L; Tope WD; Lee PK; Elmets C; Provost N; Chan A; Neyndorff H; Su XY; Jain H; Hamzavi I; McLean D; Bissonnette R
    Arch Dermatol; 2004 Jan; 140(1):26-32. PubMed ID: 14732656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationships of mono-substituted trisulfonated porphyrazines for the photodynamic therapy (PDT) of cancer.
    Cauchon N; Ali H; Hasséssian HM; van Lier JE
    Photochem Photobiol Sci; 2010 Mar; 9(3):331-41. PubMed ID: 20221459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.